搜尋結果
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 2 日前Johnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering ...
Take Five: Which way to look first?
Reuters· 2 日前U.S. Federal Reserve and Bank of Japan meetings, a G7 gathering, plus key U.S. inflation and UK jobs data are all coming ...
As 2024 Midpoint Nears, What’s Next For Stocks, Metals, Options?
Forbes· 2 日前Where do things stand with stocks, precious metals? The options markets? What’s likely to< .. ...
Waystar Prices IPO at Midpoint to Raise $968 Million
Bloomberg· 3 日前Have a confidential tip for our reporters? Health-care payments software maker Waystar Holding ...
EQT-Backed Waystar Weighs Pricing IPO Around Mid-Range
Bloomberg· 3 日前Health-care payments software maker Waystar Holding Corp. is considering pricing its initial ...
Exclusive: Healthcare software firm Waystar eyes pricing IPO at midpoint of indicated range - ...
Reuters· 3 日前At the middle of the $20-to-$23-per-share range, the< ...
This 'quasi monopoly' chip stock will drive AI trend for the next decade, says fund ...
CNBC· 4 日前The company dominates the market for lithography equipment, a central step in < ...
Jack Daniel's maker Brown-Forman beats quarterly profit estimates on price hikes
Reuters· 4 日前Jack Daniel's maker Brown-Forman beat fourth-quarter profit expectations on Wednesday, as ...
Economists expect Bank of Canada to cut interest rate Wednesday
Reuters· 4 日前The Bank of Canada (BoC) is likely to cut its key overnight rate for the& ...
It’s Not Over Yet: 6 Tricks For Setting Goals For The Rest Of The Year
Forbes· 4 日前June’s an interesting month, because it was the end of the year when we were kids, ...